The commercial corporation of advanced therapies, an opportunity to leverage Spanish devel... 14/03/2024 With the creation of this commercial corporation, it is expected to "bring two advanced therapies to authorization and... AseBio
Biotechnology to reduce the risk of kidney transplant failure and adverse events related t... 14/03/2024 Healthcare Innovative drugs Personalized medicine On the occasion of World Kidney Day, we interviewed Isabel Portero, founder and CEO of Biophope, a biotechnology company... AseBio - Biohope
Mahana Therapeutics acquires Cara Care (Asabys) to become a global platform for digital th... 12/03/2024 Healthcare Financing Corporate The combination creates a global company that offers the most comprehensive digestive health portfolio available today. Partners - Asabys Partners
Global DAO Congress Del 11/04/2024 14:00 to 11/04/2024 Healthcare DR Healthcare launches the III edition of the Global DAO Congress (#DAO24), an event on the field of Diamine Oxidase...
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 11/03/2024 Healthcare Rare diseases Advanced therapies Financing AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug... Partners - Ability Pharmaceuticals
Patient-Centric Design in the Development of Healthcare Solutions 06/03/2024 Healthcare How can Life Sciences companies ensure that the solutions they spend years developing truly respond to patient needs? Partners
Where to find Biobide in March 2024 🔎 05/03/2024 Healthcare Climate change Agrifood Circular economy Communication Corporate Meet our team at the 2024 Society of Toxicology (SOT) Annual Meeting and ToxExpo We will also attend BioEurope Spring... Partners - Biotechnology Assets
Where to find BIAT GROUP in March 2024 🔎 05/03/2024 Healthcare Climate change Agrifood Gene editing International Communication Corporate 2024 Smart Agrifood Summit; TRANSFIERE 2024, 3rd European Meeting on Science, Technology and Innovation! Partners - Biotechnology Assets
Spanish researchers to design proteins using AI to make advanced therapies more efficient 04/03/2024 Healthcare Rare diseases Financing The project will be undertaken by a public-private consortium formed by VIVEbiotech, Integra Therapeutics and OneChain... Partners - VIVEbiotech
OneChain Immunotherapeutics has received 1.3M euro grant to advance a new promising CAR T ... 29/02/2024 Healthcare Rare diseases Advanced therapies A consortium led by the Spanish company OneChain Immunotherapeutics has received 1.9M euros from the Spanish Ministry of... Partners - Parc Científic de Barcelona
